|
|
Volumn 35, Issue 3, 2012, Pages 485-487
|
|
Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEMOGLOBIN A1C;
LIVER ENZYME;
PLACEBO;
PREDNISONE;
TASPOGLUTIDE;
ABDOMINAL PAIN;
ADULT;
AGED;
ANGINA PECTORIS;
ARTICLE;
BRAIN ISCHEMIA;
CONTROLLED STUDY;
DIABETES CONTROL;
DIABETIC DIET;
DIABETIC PATIENT;
DIARRHEA;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FATALITY;
DRUG HYPERSENSITIVITY;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG WITHDRAWAL;
EXERCISE;
GASTROINTESTINAL TOXICITY;
HEART PALPITATION;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
HYPOGLYCEMIA;
INJECTION SITE INDURATION;
INJECTION SITE NODULE;
INJECTION SITE PRURITUS;
INJECTION SITE REACTION;
LARYNX EDEMA;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
MULTICENTER STUDY;
NAUSEA;
NECK PAIN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREATITIS;
PHASE 3 CLINICAL TRIAL;
PROSTATE HYPERTROPHY;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TONGUE EDEMA;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNSTABLE ANGINA PECTORIS;
URTICARIA;
VOMITING;
WEIGHT REDUCTION;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
BLOOD GLUCOSE;
BODY WEIGHT;
DIABETES MELLITUS, TYPE 2;
DOUBLE-BLIND METHOD;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MIDDLE AGED;
PEPTIDES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 84859073016
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc11-1942 Document Type: Article |
|
Times cited : (36)
|
|
References (2)
|
